无症状重度退行性二尖瓣反流的风险分层与干预策略
退行性二尖瓣病常见,近四分之一患者虽重度反流但无症状。现行指南干预指征基于左室尺寸和射血分数,并考虑房颤、肺动脉高压和左房扩大。新风险标志物包括左室/左房应变、延迟钆增强心肌纤维化、二尖瓣环分离和室性心律失常负荷,需借助机器学习和人工智能整合识别高危表型以早期干预。瓣膜修复是推荐干预,修复率和耐久性依赖术者及中心体积和瓣膜特征,机器人手术可能提高修复率但需更大数据集证实。
要点
- 近1/4退行性二尖瓣病患者虽重度反流但无症状。
- 现行指南干预指征基于左室尺寸和射血分数,并考虑房颤、肺动脉高压和左房扩大。
- 新风险标志物(应变、纤维化、二尖瓣环分离、心律失常负荷)需整合识别高危表型。
核心结论
- 无症状重度退行性二尖瓣反流患者按现行指南干预后仍存在术后心衰和死亡风险,需整合新风险标志物识别高危表型以早期干预。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- 近四分之一退行性二尖瓣病患者虽重度反流但无症状。
- 现行指南干预指征 centred on 左室尺寸和射血分数,并考虑房颤、肺动脉高压和左房扩大。
- 按现行推荐干预后患者仍存在术后心衰和死亡风险。
- 新风险标志物包括左室和左房应变、延迟钆增强显示的心肌纤维化、二尖瓣环分离和室性心律失常负荷。
- 瓣膜修复率和耐久性依赖术者和中心体积以及瓣膜特征,机器人手术可能提高修复率但需更大数据集证实。
关键数值与推荐
- 现行指南干预指征基于左室尺寸和射血分数,并考虑房颤、肺动脉高压和左房扩大。
- 瓣膜修复是推荐干预。
临床怎么用
- 对无症状重度退行性二尖瓣反流患者,除左室尺寸和射血分数外,可评估左室/左房应变、心肌纤维化、二尖瓣环分离和室性心律失常负荷以识别高危表型。
- 借助机器学习和人工智能整合新标志物,识别可从早期干预获益的高危表型。
- 优先选择瓣膜修复,并考虑术者和中心体积对修复率和耐久性的影响。
局限性
- 将新风险标志物转化至临床实践需整合并识别高危表型,尚需进一步验证。
- 机器人手术提高修复率需更大数据集证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Degenerative mitral valve disease is common. Up to a quarter of patients with degenerative mitral valve disease may be asymptomatic despite having severe valve regurgitation. Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrial fibrillation, pulmonary hypertension and those with left atrial dilatation. However, despite intervention according to these recommendations, patients remain at risk of post-operative heart failure and mortality. Newer risk markers have been developed including left ventricular and atrial strain, myocardial fibrosis demonstrated using late gadolinium enhancement, mitral annular disjunction and ventricular arrhythmia burden. Translating newer markers into clinical practice will require integrating and identifying high-risk phenotypes that benefit from early intervention using machine learning techniques and artificial intelligence. Valve repair is the recommended intervention. However, repair rate and durability are dependent on both operator and centre volumes as well as valve characteristics. Recent advancements, including robotic surgery, may enhance repair rates; however, larger datasets are necessary to confirm these improvements. Efforts should focus on establishing high-volume regional centres of excellence for mitral valve repair.
引用
- Björn R, Strom JB, Lloyd G, et al. Asymptomatic severe degenerative mitral regurgitation. Heart. 2024. PMID: 39515991. doi:10.1136/heartjnl-2024-324739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。